missing translation for 'onlineSavingsMsg'
Learn More

CXCR2/IL-8RB Antibody (HC2), FITC, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Bio-Techne NBP3-12005F

Product Code. 18321822

  • 5815.00 SEK / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

CXCR2/IL-8RB Monoclonal antibody specifically detects CXCR2/IL-8RB in Human samples. It is validated for Flow Cytometry, Immunofluorescence
Specifications

Specifications

CXCR2/IL-8RB
Monoclonal
FITC
PBS
Rabbit
Protein A purified
RUO
Primary
Human
Purified
Flow Cytometry, Immunofluorescence
HC2
Flow Cytometry, Immunocytochemistry/Immunofluorescence
CD182 antigen, CDw128b, chemokine (C-X-C motif) receptor 2, chemokine (CXC) receptor 2, C-X-C chemokine receptor type 2, CXC-R2, CXCR-2, CXCR2 gene for IL8 receptor type B, GRO/MGSA receptor, High affinity interleukin-8 receptor B, IL-8 receptor type 2, IL-8R B, IL8R2, IL8RA, interleukin 8 receptor B, interleukin 8 receptor type 2, interleukin-8 receptor type B
This antibody was raised by immunizing mice with human IL-8 (interleukin-8) receptor, type B.
0.1 mL
Angiogenesis, Cancer, Chemokines and Cytokines, Cytokine Research, GPCR, Immunology, Innate Immunity, Myeloid derived Suppressor Cell
3579
Store at 4C in the dark.
IgG κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.